Contacts Investor and Media Contact: Naresh Tanna Vice President of Investor Relations Naresh.Tanna@precisionbiosciences.com Precision BioSciences, Inc. (Nasdaq: DTIL) (the “Company”),...
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused...
Blink Care is an optional maintenance program designed to reduce charger downtime and provide a more seamless charging experience.Read more...
Contacts Shane Kleinstein (720) 875-5432 Atlanta Braves Holdings, Inc. (“ABH”) (Nasdaq: BATRA, BATRK) today reported first quarter 2024 results. Headlines...
Contacts Shane Kleinstein (720) 875-5432 Atlanta Braves Holdings, Inc. (“ABH”) (Nasdaq: BATRA, BATRK) today reported first quarter 2024 results. Headlines...
AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical...
authID to secure leading IAM provider’s workforce and customer identity clients across North America from malicious, generative AI-driven cyberattacksDENVER, May...
Contacts Astria: Investor Relations and Media: Elizabeth Higgins investors@astriatx.com Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing...
Heavily pre-treated breast cancer patient who achieved stable disease on study, remains on treatment for more than eleven months after...
DALLAS, May 08, 2024 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the "Company"), a designer, builder,...
Contacts AdaptHealth Corp. Jason Clemens, CFA Chief Financial Officer Investor Relations ICR Westwicke IR@adapthealth.com AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or...
CHARLOTTESVILLE, Va., May 08, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel...
Fully enrolled registration-intended PRECISION1 trial; two-thirds interim analysis planned for Q3 2024 FYARRO® sales of $5.4 million for Q1 2024, reflects...
Total Revenue Increased 25% to $51.3 MillionRecord First Quarter MACI Revenue of $40.2 Million and Burn Care Revenue Growth of...
Contacts For Investors: Angela Bitting SVP, Corporate Affairs 925-202-6211 abitting@twistbioscience.com For Media: Amanda Houlihan Communications Manager 774-265-5334 ahoulihan@twistbioscience.com As required...
Total assets under management of $224 billion as of March 31, 2024, an increase of 63% compared to $137 billion...
WASHINGTON, May 08, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused...
WASHINGTON, May 08, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused...
CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on...
Contacts Sam Sova Partner and CEO SOVA Sam@letsgosova.com Soluna Holdings, Inc. (“Soluna” or the “Company”), (NASDAQ: SLNH), a developer of...
Findings demonstrate ability of PM359 to correct disease-causing mutation in CGD patient blood stem cells, leading to restored immune function...
Collaboration between Premier, AstraZeneca and leading health systems will leverage real-world data, artificial intelligence-powered technologies and scalable solutions to help...
Company earns Gold Seal of Approval® for Ambulatory Health Care AccreditationPETACH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- NANO-X...
New Long Beach station advances Nikola's commitment to sustainable transportation solutions PHOENIX, May 8, 2024 /PRNewswire/ -- Nikola Corporation (Nasdaq:...
Measured across five solution capabilities, NICE Actimize scored highly in entity management, workflow and automation, and system interfaces and APIs...
Company intends to expand service offerings to include Reg A+ and Reg D deals and broker-dealer partnerships Contacts Investor Contact...
Company intends to expand service offerings to include Reg A+ and Reg D deals and broker-dealer partnerships Contacts Investor Contact...
HONG KONG, May 8, 2024 /PRNewswire/ -- MMTEC, Inc. ("MMTEC" or the "Company") (Nasdaq: MTC), announced that it will suspend...
CORONA, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (NASDAQ: MNST) today announced that it has commenced a...
THE WOODLANDS, Texas, May 8, 2024 /PRNewswire/ -- MIND Technology, Inc. ("MIND" or the "Company") (Nasdaq: MIND) (Nasdaq: MINDP) announced...
THE WOODLANDS, Texas, May 8, 2024 /PRNewswire/ -- MIND Technology, Inc. ("MIND" or the "Company") (Nasdaq: MIND) (Nasdaq: MINDP) announced...
LEXINGTON, Ky., May 8, 2024 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB) ("Ramaco" or the "Company") announced that its...
SALT LAKE CITY, May 8, 2024 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company, today announced that data from...
RIVERBANK, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced the opening of its second...
LEXINGTON, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical...
IRVINE, Calif., May 8, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is...
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage...
Company generates strong earnings and margins, continued execution of omnichannel strategyCompany to Host Conference Call Today at 9 a.m. ETRead...
Contacts Investor Contact Max Rosett Interim Chief Financial Officer investors@immunome.com Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing...
IMC prepares for accelerated growth after legalization in Germany and recovers from the impact of the Israel-Hamas war. TORONTO and GLIL...
